Pimozide Tablet Market Report 2026

Pimozide Tablet Market Overview

• Pimozide Tablet market size has reached to $1.84 billion in 2025 • Expected to grow to $2.91 billion in 2030 at a compound annual growth rate (CAGR) of 9.5% • Growth Driver: Impact Of Rising Psychiatric Disorder Prevalence On The Pimozide Tablet Market • North America was the largest region in 2025.

What Is Covered Under Pimozide Tablet Market?

Pimozide tablets are antipsychotic medications primarily used to treat Tourette's syndrome and chronic psychosis. They work by blocking dopamine receptors in the brain, which helps reduce symptoms such as tics and hallucinations. These tablets are typically prescribed when other treatments have not been effective. The main types of pimozide tablets are 1 milligram, 2 milligrams, and 4 milligrams. Pimozide 1 mg tablets contain the active ingredient pimozide and inactive ingredients calcium stearate, microcrystalline cellulose, lactose anhydrous, and corn starch. The distribution channels are online and offline, and the application includes Tourette's syndrome and chronic schizophrenia. It is used by various end users, such as hospitals, clinics, and home use.

What Is The Pimozide Tablet Market Growth Forecast?

The pimozide tablet market size is expected to see strong growth in the next few years. It will grow to $2.91 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to development of low-dose and unit-dose pimozide tablets, expansion of online pharmacy platforms, rising home healthcare adoption, increasing government mental health initiatives, integration of digital adherence monitoring tools. Major trends in the forecast period include increasing awareness of tourette’s syndrome and chronic schizophrenia, rising preference for oral antipsychotic medications, growth in home-based mental health care and therapy, expansion of online pharmaceutical distribution channels, development of personalized dosing and packaging options.

Global Pimozide Tablet Market Segmentation

1) By Type: 1 Milligram, 2 Milligram, 4 Milligram 2) By Distribution Channel: Online, Offline 3) By Application: Tourette's Syndrome, Chronic Schizophrenia 4) By End User: Hospitals, Clinics, Home Use

What Are The Drivers Of The Pimozide Tablet Market?

The rising prevalence of psychiatric disorders is expected to propel the growth of the pimozide tablet market going forward. Psychiatric disorders are mental health conditions characterized by significant disturbances in thoughts, emotions, or behaviors, leading to distress or impaired functioning. The rising prevalence of psychiatric disorders is primarily attributed to factors such as increased stress levels, changing societal norms, better awareness and diagnosis, and genetic predispositions. Pimozide tablets are used in psychiatric disorders to manage symptoms such as delusions and tics by blocking dopamine receptors, thereby helping to reduce abnormal brain activity. For instance, in August 2025, according to the Substance Abuse and Mental Health Services Administration (SAMHSA), a US-based federal agency, 23.4% of adults aged 18 or older (about 61.5 million people) experienced any mental illness (AMI), with about 5.6 % reporting a serious mental illness (SMI). Comparatively, 22.8 % (58.7 million people) and 5.7 % (14.6 million people) of adults reported AMI and SMI, respectively, in 2023. Therefore, the rising prevalence of psychiatric disorders is driving the pimozide tablet industry. The increase in healthcare expenditure is expected to propel the growth of the pimozide tablet market going forward. Healthcare expenditures are rising due to the increasing cost of advanced medical technologies, aging populations, and the prevalence of chronic diseases. Increasing healthcare expenditure drives the demand for Pimozide tablets by improving access to mental health treatments and supporting broader insurance coverage for psychiatric medications. For instance, in May 2024, according to the Office for National Statistics, a UK-based government department, healthcare expenditure in the UK increased from £277 ($319.91) billion in 2022 to £292 ($337.23) billion in 2023, reflecting a rise in nominal terms compared to the previous year. Therefore, the increase in healthcare expenditure is driving the growth of the pimozide tablet industry. The increasing investment in pharmaceutical manufacturing is expected to propel the growth of the pimozide tablet market going forward. Pharmaceutical manufacturing is the process of producing medicines by combining, processing, and packaging chemical or biological substances under strict quality standards to ensure they are safe, effective, and suitable for patient use. Pharmaceutical manufacturing is rising due to the increasing demand for affordable generic medicines, which drives companies to expand production to meet the growing healthcare needs of patients. Pimozide tablets contribute to pharmaceutical manufacturing by providing a marketable CNS medication that drives production, formulation, and distribution activities within the industry. For instance, in June 2025, according to the Les Entreprises du Médicament (Leem), a French-based professional organization representing pharmaceutical companies in France, manufacturing-related investment in France increased by 38% in 2024 compared to 2023. Therefore, increasing investment in pharmaceutical manufacturing is driving the growth of the pimozide tablet industry.

Key Players In The Global Pimozide Tablet Market

Major companies operating in the pimozide tablet market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Bristol-Myers Squibb, GlaxoSmithKline plc, C.H. Boehringer Sohn AG & Co. KG, Teva Pharmaceutical Industries Ltd., Hetero Drugs, Sun Pharmaceutical Industries Ltd., Jazz Pharmaceuticals, Aurobindo Pharma, Cipla Limited, Apotex Inc., H. Lundbeck A/S, Dr. Reddy's Laboratories, Hikma Pharmaceuticals, Amneal Pharmaceuticals, Endo International, Lupin Limited, Zydus Cadila, Alkem Laboratories, Torrent Pharmaceuticals, Glenmark Pharmaceuticals, Mallinckrodt Pharmaceuticals, Jubilant Life Sciences, Alembic Pharmaceuticals, Wockhardt, AA Pharma, Taj Pharmaceuticals

Regional Insights

North America was the largest region in the pimozide tablet market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Pimozide Tablet Market?

The pimozide tablet market consists of sales of orap, orap forte, and opiran. The market value includes the value of related goods sold by the service provider or included within the service offering. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Pimozide Tablet Market Report 2026?

The pimozide tablet market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pimozide tablet industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.